GenScript Biotech Corporation, a global provider of life science research and manufacturing services, has been awarded a Silver Medal by EcoVadis, a globally recognized business sustainability assessment platform. This achievement places GenScript in the top 15% of companies worldwide assessed for their sustainability practices. The company, which is a member of the United Nations Global Compact and a supplier partner of the Pharmaceutical Supply Chain Initiative, has made significant advancements in areas such as environment, labor and human rights, ethics, and sustainable procurement. GenScript's sustainability efforts are further supported by an "A" rating from MSCI ESG Ratings, a "Low Risk" rating from Morningstar Sustainalytics, and inclusion in the FTSE4Good Index Series. The company's carbon reduction targets have been approved by the Science Based Targets initiative, emphasizing its commitment to addressing climate change.